Phosphorylated ERα, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast Cancer | Zendy

AI Assistant Blog Pricing

Phosphorylated ERα, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast Cancer

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.

Welcome back

Please enter your details.

Email*

Password*

Remember me

OR LOG IN WITH

Google

Facebook

Apple

Don't have an account? Sign Up